BiotechTube

Human Acellular Vessel (HAV)

Phase 2/3Active
0 watching 0 views this week⚡ Active
57
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Trauma

Conditions

Trauma, Vascular System Injury

Trial Timeline

Sep 1, 2018 → Sep 1, 2027

NCT ID
NCT03005418

About Human Acellular Vessel (HAV)

Human Acellular Vessel (HAV) is a phase 2/3 stage product being developed by Humacyte for Trauma. The current trial status is active. This product is registered under clinical trial identifier NCT03005418. Target conditions include Trauma, Vascular System Injury.

Hype Score Breakdown

Clinical
22
Activity
15
Company
2
Novelty
7
Community
8

Clinical Trials (4)

NCT IDPhaseStatus
NCT03005418Phase 2/3Active
NCT03183245Phase 3Completed
NCT02887859Phase 2Completed
NCT02644941Phase 3Completed

Competing Products

20 competing products in Trauma

See all competitors
ProductCompanyStageHype Score
Duloxetine + Sugar pillEli LillyPhase 2
52
Neurosteroid enantiomerOragenicsPhase 2
44
Transdermal Patch + Loxoprofen sodium + Placebo (for loxoprofen sodium) + Placebo (for transdermal patch)Daiichi SankyoPhase 3
77
CelecoxibAstellas PharmaPre-clinical
23
Mupirocin Calcium Cream, 2% + Bactroban® Cream + Cream vehicle of test productSun PharmaceuticalPhase 1
33
Duloxetine hydrochlorideEli LillyPhase 3
77
Galcanezumab-GnlmEli LillyApproved
85
SYN117 (nepicastat) + Placebo comparatorJohnson & JohnsonPhase 2
52
Nepicastat + PlaceboJohnson & JohnsonPhase 2
52
JNJ-17299425Johnson & JohnsonPhase 2
52
Placebo + sertralineJohnson & JohnsonApproved
85
Quetiapine Fumarate + quetiapine fumarate placeboAstraZenecaPhase 3
77
Adjunctive asenapineMerckApproved
85
Rizatriptan + PlaceboMerckPre-clinical
23
AlendronateMerckApproved
85
Iloperidone + PlaceboNovartisPhase 2
52
AMG 334NovartisPhase 2
52
RivastigmineNovartisPhase 3
77
RivastigmineNovartisApproved
85
Balovaptan + PlaceboRochePhase 2
52

Other Products from Humacyte

Acellular Tissue Engineered Vessel (ATEV)Phase 3
69
Human Acellular Vessel (HAV)Phase 3
69
Human Acellular Vessel (HAV)Phase 3
69
Human Acellular Vessel (HAV)Phase 2
44
HAVPhase 2
44